Coronavirus Medical Misinformation

Throughout the pandemic, several treatments received widespread media and political attention without clinical evidence to support them. Here is what the clinical trials actually showed.

Written and researched by Andy Wilcox · Last reviewed: May 2026

Last reviewed: June 2, 2026

Debunked COVID Treatments

Not Effective

Hydroxychloroquine / Chloroquine

The claim: Hydroxychloroquine (HCQ), an antimalarial drug, could prevent or treat COVID-19 based on early in vitro studies and anecdotal reports. The claim received prominent political endorsement in the U.S. in March–April 2020.

The evidence: Multiple large, randomized controlled trials — including the WHO SOLIDARITY trial[M1] (enrolling 11,266 patients), the RECOVERY trial[M2] (4,716 patients), and the NIH ORCHID trial — found no benefit of HCQ in reducing mortality, time to discharge, or disease progression in hospitalized COVID-19 patients. The FDA revoked its Emergency Use Authorization for HCQ in June 2020 after safety concerns, including cardiac arrhythmia risk, emerged alongside the null efficacy data.

Why it doesn't work in vivo: Although HCQ inhibited SARS-CoV-2 in cell cultures, the concentrations required exceeded those safely achievable in human lung tissue.

Not Effective

Ivermectin

The claim: Ivermectin, an antiparasitic drug, was promoted by a vocal community of physicians and online advocates as an effective COVID-19 treatment, particularly after early observational studies appeared promising.

The evidence: The TOGETHER trial[M3], a double-blind, randomized, placebo-controlled trial of 1,358 high-risk adults, found no meaningful benefit of ivermectin on hospitalization or prolonged emergency care (14.7% vs. 16.3% placebo; relative risk 0.90, 95% CI 0.70–1.16). The WHO SOLIDARITY PLUS trial similarly found no significant benefit. The Cochrane Collaboration systematic review (2022) concluded: "We are very uncertain about the efficacy and safety of ivermectin for the prevention of COVID-19."[M4] Earlier favorable studies were found to contain data irregularities.

Dangerous

Bleach / Disinfectant Injection

The claim: In April 2020, publicly speculated suggestions were made that injecting or ingesting household disinfectants might kill the virus inside the body.

The evidence: Household disinfectants (bleach, isopropyl alcohol, Lysol) are acutely toxic when ingested or injected. They cause severe chemical burns to mucous membranes, esophagus, and stomach; systemic absorption causes organ failure. Poison control centers in multiple U.S. states reported increased calls about disinfectant ingestion in the days following the public remarks. Under no circumstances should disinfectants be ingested or injected.

Not Effective

Colloidal Silver

The claim: Colloidal silver — microscopic silver particles suspended in liquid — can treat or prevent COVID-19.

The evidence: The FDA and FTC issued warnings to multiple companies making these claims. There is no scientific evidence that colloidal silver is effective against any virus, including SARS-CoV-2. Chronic ingestion causes argyria, a permanent blue-gray discoloration of the skin. The FDA has stated that colloidal silver is not generally recognized as safe or effective for any medical condition.

Not Effective

UV Light Internally

The claim: Shining ultraviolet light inside the body could kill the virus.

The evidence: UV-C light (100–280 nm) is germicidal and is used to disinfect surfaces, water, and air. It cannot be safely applied to internal tissues; UV-C radiation at germicidal wavelengths causes severe cellular damage including DNA strand breaks, and would destroy human tissue along with any virus. External UV lamps do not penetrate below the skin surface. No approved or experimental device exists that safely delivers germicidal UV light to respiratory tissues.

References

  1. Pan H, et al. "Repurposed Antiviral Drugs for Covid-19 — Interim WHO SOLIDARITY Trial Results." NEJM, 2021. doi:10.1056/NEJMoa2023184
  2. RECOVERY Collaborative Group. "Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19." NEJM, 2020. doi:10.1056/NEJMoa2022926
  3. Reis G, et al. "Effect of Early Treatment with Ivermectin among Patients with Covid-19." NEJM, 2022. doi:10.1056/NEJMoa2115869
  4. Popp M, et al. "Ivermectin for preventing and treating COVID-19." Cochrane Database of Systematic Reviews, 2022. doi:10.1002/14651858.CD015017.pub3
Andy Wilcox, independent researcher and founder of Virus Questions

Andy Wilcox

Written and researched by Andy Wilcox, an independent researcher not a physician — his work is the product of disciplined primary-source research drawing on 30+ years as a consultant, operating executive, and investor. Nothing here is medical advice.